NewslettersImmune Regulation NewsMammary Cell NewsPTPN2 Elicits Cell Autonomous and Non–Cell Autonomous Effects on Antitumor Immunity in Triple-Negative Breast CancerBy Justin.choi - February 24, 2022014Scientists explored the therapeutic potential of targeting PTPN2 in TNBC and T cells. PTPN2-deficiency in TNBC associated with T cell infiltrates and PD-L1 expression, whereas low PTPN2 associated with improved survival.[Science Advances] 6445212 AAAAAAAA items 1 apa 0 default asc 1 172215 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Full Article